Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL
 
Authors :  S. D. Gadola, N. R. Zaccai, K. Harlos, D. Shepherd, G. Ritter, R. R. Schmidt, E. Y. Jones, V. Cerundolo
Date :  24 May 02  (Deposition) - 31 Jul 02  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.26
Chains :  Asym./Biol. Unit :  A,B
Keywords :  Phophatidylinositol, Mhc, Glycoprotein, Antigen Presentation (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  S. D. Gadola, N. R. Zaccai, K. Harlos, D. Shepherd, J. C. Castro-Palomino, G. Ritter, R. R. Schmidt, E. Y. Jones, V. Cerundolo
Structure Of Human Cd1B With Bound Ligands At 2. 3 A, A Maze For Alkyl Chains
Nat. Immunol. V. 3 721 2002
PubMed-ID: 12118248  |  Reference-DOI: 10.1038/NI821

(-) Compounds

Molecule 1 - T-CELL SURFACE GLYCOPROTEIN CD1B
    ChainsA
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System PlasmidPET23D
    Expression System StrainBL21
    Expression System Taxid511693
    Expression System VectorPROKARYOTIC EXPRESSION SYSTEM
    FragmentRESIDUES 18-295
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymCD1B ANTIGEN
 
Molecule 2 - B2-MICROGLOBULIN
    ChainsB
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System Cell LineBL21
    Expression System PlasmidPET23D
    Expression System Taxid511693
    Expression System VectorPROKARYOTIC EXPRESSION SYSTEM
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (4, 6)

Asymmetric/Biological Unit (4, 6)
No.NameCountTypeFull Name
1D121Ligand/IonDODECANE
2NO33Ligand/IonNITRATE ION
3PII1Ligand/Ion2-[(HYDROXY{[(2R,3R,5S,6R)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL]OXY}PHOSPHORYL)OXY]-1-[(PALMITOYLOXY)METHYL]ETHYL HEPTADECANOATE
4TWT1Ligand/IonDOCOSANE

(-) Sites  (6, 6)

Asymmetric Unit (6, 6)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREPRO A:7 , TYR A:212 , PRO A:213 , LYS A:214 , PRO A:215 , TRP A:243 , HOH A:2027BINDING SITE FOR RESIDUE NO3 A1281
2AC2SOFTWAREGLY A:233 , ASP A:234 , ARG A:246 , GLN B:8BINDING SITE FOR RESIDUE NO3 A1282
3AC3SOFTWARELEU A:161 , THR A:165 , PII A:1280BINDING SITE FOR RESIDUE NO3 A1283
4AC4SOFTWAREILE A:69 , VAL A:72 , TYR A:73 , ALA A:100 , VAL A:126 , ALA A:129 , CYS A:131 , GLY A:153 , MET A:155 , THR A:157 , ILE A:160 , LEU A:161 , NO3 A:1283 , TWT A:1285BINDING SITE FOR RESIDUE PII A1280
5AC5SOFTWAREGLU A:80 , PHE A:84 , MET A:90 , PHE A:144 , TYR A:151 , TWT A:1285BINDING SITE FOR RESIDUE D12 A1284
6AC6SOFTWAREVAL A:12 , GLN A:14 , TRP A:40 , PHE A:70 , PHE A:123 , PII A:1280 , D12 A:1284BINDING SITE FOR RESIDUE TWT A1285

(-) SS Bonds  (4, 4)

Asymmetric/Biological Unit
No.Residues
1A:102 -A:166
2A:131 -A:145
3A:206 -A:261
4B:25 -B:80

(-) Cis Peptide Bonds  (3, 3)

Asymmetric/Biological Unit
No.Residues
1Tyr A:92 -Pro A:93
2Tyr A:212 -Pro A:213
3His B:31 -Pro B:32

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (1, 1)

Asymmetric/Biological Unit (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_076691D96NB2MG_HUMANDisease (AMYL8)398122820BD76N

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 1)

Asymmetric/Biological Unit (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1IG_MHCPS00290 Immunoglobulins and major histocompatibility complex proteins signature.B2MG_GORGO98-104  1B:78-84
B2MG_HUMAN98-104  1B:78-84
B2MG_PANTR98-104  1B:78-84

(-) Exons   (8, 8)

Asymmetric/Biological Unit (8, 8)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENSPTRT000000129561aENSPTRE00000370636chr15:41860468-41860604137B2MG_PANTR1-23231B:0-34
1.2aENSPTRT000000129562aENSPTRE00000238527chr15:41864413-41864691279B2MG_PANTR23-116941B:3-9694
1.4ENSPTRT000000129564ENSPTRE00000238528chr15:41865318-4186534528B2MG_PANTR116-11941B:96-994
1.5ENSPTRT000000129565ENSPTRE00000070423chr15:41866598-41867140543B2MG_PANTR-00--

2.1ENST000003681681ENSE00001446457chr1:158301321-158301153169CD1B_HUMAN1-21211A:3-31
2.2aENST000003681682aENSE00001039203chr1:158300852-158300586267CD1B_HUMAN21-110901A:3-9290
2.3ENST000003681683ENSE00001039193chr1:158299920-158299642279CD1B_HUMAN110-203941A:92-18594
2.4bENST000003681684bENSE00001039201chr1:158299438-158299160279CD1B_HUMAN203-296941A:185-27894
2.5ENST000003681685ENSE00001039199chr1:158298804-15829871194CD1B_HUMAN296-327321A:278-280 (gaps)17
2.6aENST000003681686aENSE00001598880chr1:158298047-158297741307CD1B_HUMAN327-33370--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:278
 aligned with CD1B_HUMAN | P29016 from UniProtKB/Swiss-Prot  Length:333

    Alignment length:292
                                    30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310  
           CD1B_HUMAN    21 AFQGPTSFHVIQTSSFTNSTWAQTQGSGWLDDLQIHGWDSDSGTAIFLKPWSKGNFSDKEVAELEEIFRVYIFGFAREVQDFAGDFQMKYPFEIQGIAGCELHSGGAIVSFLRGALGGLDFLSVKNASCVPSPEGGSRAQKFCALIIQYQGIMETVRILLYETCPRYLLGVLNAGKADLQRQVKPEAWLSSGPSPGPGRLQLVCHVSGFYPKPVWVMWMRGEQEQQGTQLGDILPNANWTWYLRATLDVADGEAAGLSCRVKHSSLEGQDIILYWRNPTSIGSIVLAIIVPS 312
               SCOP domains d1gzqa2 A:3-183 CD1, alpha-1 and alpha-2 domains                                                                                                                                     d1gzqa1 A:184-280 CD1, alpha-3 domain                                                                           SCOP domains
               CATH domains ----1gzqA01 A:7-182 Murine Class I Major Histocompatibility Complex, H2-DB, subunit A, domain 1                                                                                     1gzqA02 A:183-278 Immunoglobulins                                                               ---------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......eeeeeeeeeeee..eeeeeeeeee..eeeeeee....eeee.........hhhhhhhhhhhhhhhhhhhhhhhhhhh........eeeeeeeeeee.....eeeeeeeee..eeeeeee..eeee...hhhhhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.....eeeeee.......eeeeeeeeeee.....eeeeee..ee....ee...eee...eeeeeeeeeee.hhh..eeeeeehhhhh...eeee..--------------.. Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2----------------------------------------------------------------------------------------Exon 2.3  PDB: A:92-185 UniProt: 110-203                                                      --------------------------------------------------------------------------------------------Exon 2.5          Transcript 2 (1)
           Transcript 2 (2) Exon 2.2a  PDB: A:3-92 UniProt: 21-110                                                    --------------------------------------------------------------------------------------------Exon 2.4b  PDB: A:185-278 UniProt: 203-296                                                    ---------------- Transcript 2 (2)
                 1gzq A   3 AFQGPTSFHVIQTSSFTNSTWAQTQGSGWLDDLQIHGWDSDSGTAIFLKPWSKGNFSDKEVAELEEIFRVYIFGFAREVQDFAGDFQMKYPFEIQGIAGCELHSGGAIVSFLRGALGGLDFLSVKNASCVPSPEGGSRAQKFCALIIQYQGIMETVRILLYETCPRYLLGVLNAGKADLQRQVKPEAWLSSGPSPGPGRLQLVCHVSGFYPKPVWVMWMRGEQEQQGTQLGDILPNANWTWYLRATLDVADGEAAGLSCRVKHSSLEGQDIILYWG--------------PG 280
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272     |   -         -| 
                                                                                                                                                                                                                                                                                                             278            279 

Chain B from PDB  Type:PROTEIN  Length:100
 aligned with B2MG_GORGO | P61771 from UniProtKB/Swiss-Prot  Length:119

    Alignment length:100
                                    29        39        49        59        69        79        89        99       109       119
           B2MG_GORGO    20 AIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM 119
               SCOP domains d1gzqb_ B: beta2-microglobulin                                                                       SCOP domains
               CATH domains 1gzqB00 B:0-99 Immunoglobulins                                                                       CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......eeeeee.........eeeeeeeeee.....eeeeee..ee....ee...ee.....eeeeeeeee.......eeeeee.......eeee..... Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------N----------------------- SAPs(SNPs)
                PROSITE (2) ---------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) ------------------------------------------------------------------------------IG_MHC --------------- PROSITE (3)
                 Transcript ---------------------------------------------------------------------------------------------------- Transcript
                 1gzq B   0 MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM  99
                                     9        19        29        39        49        59        69        79        89        99

Chain B from PDB  Type:PROTEIN  Length:100
 aligned with B2MG_HUMAN | P61769 from UniProtKB/Swiss-Prot  Length:119

    Alignment length:100
                                    29        39        49        59        69        79        89        99       109       119
           B2MG_HUMAN    20 AIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM 119
               SCOP domains d1gzqb_ B: beta2-microglobulin                                                                       SCOP domains
               CATH domains 1gzqB00 B:0-99 Immunoglobulins                                                                       CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......eeeeee.........eeeeeeeeee.....eeeeee..ee....ee...ee.....eeeeeeeee.......eeeeee.......eeee..... Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------N----------------------- SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------------------IG_MHC --------------- PROSITE
                 Transcript ---------------------------------------------------------------------------------------------------- Transcript
                 1gzq B   0 MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM  99
                                     9        19        29        39        49        59        69        79        89        99

Chain B from PDB  Type:PROTEIN  Length:100
 aligned with B2MG_PANTR | P61770 from UniProtKB/Swiss-Prot  Length:119

    Alignment length:100
                                    29        39        49        59        69        79        89        99       109       119
           B2MG_PANTR    20 AIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM 119
               SCOP domains d1gzqb_ B: beta2-microglobulin                                                                       SCOP domains
               CATH domains 1gzqB00 B:0-99 Immunoglobulins                                                                       CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......eeeeee.........eeeeeeeeee.....eeeeee..ee....ee...ee.....eeeeeeeee.......eeeeee.......eeee..... Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------N----------------------- SAPs(SNPs)
                PROSITE (2) ------------------------------------------------------------------------------IG_MHC --------------- PROSITE (2)
           Transcript 1 (1) 1.1a--------------------------------------------------------------------------------------------1.4  Transcript 1 (1)
           Transcript 1 (2) ---Exon 1.2a  PDB: B:3-96 UniProt: 23-116                                                        --- Transcript 1 (2)
                 1gzq B   0 MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM  99
                                     9        19        29        39        49        59        69        79        89        99

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (3, 3)

Asymmetric/Biological Unit

(-) CATH Domains  (2, 3)

Asymmetric/Biological Unit
(-)
Class: Alpha Beta (26913)
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 1GZQ)

(-) Gene Ontology  (65, 114)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (CD1B_HUMAN | P29016)
molecular function
    GO:0030881    beta-2-microglobulin binding    Interacting selectively and non-covalently with beta-2-microglobulin.
    GO:0030883    endogenous lipid antigen binding    Interacting selectively and non-covalently with an endogenous cellular lipid antigen.
    GO:0030884    exogenous lipid antigen binding    Interacting selectively and non-covalently with an exogenous lipid antigen (examples include microbial lipids and glycolipids).
    GO:0071723    lipopeptide binding    Interacting selectively and non-covalently with a lipopeptide, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds and containing a nonprotein group consisting of a lipid or lipids.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
    GO:0002250    adaptive immune response    An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
    GO:0048007    antigen processing and presentation, exogenous lipid antigen via MHC class Ib    The process in which an antigen-presenting cell expresses lipid antigen of exogenous origin in association with an MHC class Ib protein complex on its cell surface. Class Ib here refers to non-classical class I molecules, such as those of the CD1 family.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
    GO:0050776    regulation of immune response    Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
cellular component
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0010008    endosome membrane    The lipid bilayer surrounding an endosome.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005765    lysosomal membrane    The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
    GO:0005764    lysosome    A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain B   (B2MG_GORGO | P61771)
biological process
    GO:0002474    antigen processing and presentation of peptide antigen via MHC class I    The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
cellular component
    GO:0042612    MHC class I protein complex    A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

Chain B   (B2MG_HUMAN | P61769)
molecular function
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
    GO:0033077    T cell differentiation in thymus    The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
    GO:0019731    antibacterial humoral response    An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.
    GO:0019885    antigen processing and presentation of endogenous peptide antigen via MHC class I    The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
    GO:0002479    antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent    The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
    GO:0002480    antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent    The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
    GO:0002481    antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent    The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
    GO:0002474    antigen processing and presentation of peptide antigen via MHC class I    The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
    GO:0044267    cellular protein metabolic process    The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
    GO:0071281    cellular response to iron ion    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
    GO:0071222    cellular response to lipopolysaccharide    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0050829    defense response to Gram-negative bacterium    Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
    GO:0050830    defense response to Gram-positive bacterium    Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
    GO:0045087    innate immune response    Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
    GO:0060333    interferon-gamma-mediated signaling pathway    A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.
    GO:0055072    iron ion homeostasis    Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
    GO:0010977    negative regulation of neuron projection development    Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
    GO:1900121    negative regulation of receptor binding    Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor.
    GO:0002726    positive regulation of T cell cytokine production    Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.
    GO:0001916    positive regulation of T cell mediated cytotoxicity    Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
    GO:1904434    positive regulation of ferrous iron binding    Any process that activates or increases the frequency, rate or extent of ferrous iron binding.
    GO:0032092    positive regulation of protein binding    Any process that activates or increases the frequency, rate or extent of protein binding.
    GO:1900122    positive regulation of receptor binding    Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.
    GO:0048260    positive regulation of receptor-mediated endocytosis    Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
    GO:1904437    positive regulation of transferrin receptor binding    Any process that activates or increases the frequency, rate or extent of transferrin receptor binding.
    GO:0042026    protein refolding    The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones.
    GO:0050690    regulation of defense response to virus by virus    Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism.
    GO:0050776    regulation of immune response    Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
    GO:0003254    regulation of membrane depolarization    Any process that modulates the rate, frequency or extent of membrane depolarization. Membrane depolarization is the process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive.
    GO:0046686    response to cadmium ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
    GO:0042493    response to drug    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0002237    response to molecule of bacterial origin    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
    GO:0001895    retina homeostasis    A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
cellular component
    GO:0012507    ER to Golgi transport vesicle membrane    The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi.
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:0000139    Golgi membrane    The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
    GO:1990712    HFE-transferrin receptor complex    A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription.
    GO:0042612    MHC class I protein complex    A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031905    early endosome lumen    The volume enclosed by the membrane of an early endosome.
    GO:0031901    early endosome membrane    The lipid bilayer surrounding an early endosome.
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005925    focal adhesion    Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0030670    phagocytic vesicle membrane    The lipid bilayer surrounding a phagocytic vesicle.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain B   (B2MG_PANTR | P61770)
molecular function
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
biological process
    GO:0033077    T cell differentiation in thymus    The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
    GO:0019731    antibacterial humoral response    An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.
    GO:0019885    antigen processing and presentation of endogenous peptide antigen via MHC class I    The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
    GO:0002481    antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent    The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
    GO:0002474    antigen processing and presentation of peptide antigen via MHC class I    The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
    GO:0071281    cellular response to iron ion    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
    GO:0071222    cellular response to lipopolysaccharide    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0050829    defense response to Gram-negative bacterium    Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
    GO:0050830    defense response to Gram-positive bacterium    Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
    GO:0045087    innate immune response    Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
    GO:0055072    iron ion homeostasis    Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
    GO:0010977    negative regulation of neuron projection development    Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
    GO:1900121    negative regulation of receptor binding    Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor.
    GO:0002726    positive regulation of T cell cytokine production    Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.
    GO:0001916    positive regulation of T cell mediated cytotoxicity    Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
    GO:1904434    positive regulation of ferrous iron binding    Any process that activates or increases the frequency, rate or extent of ferrous iron binding.
    GO:0032092    positive regulation of protein binding    Any process that activates or increases the frequency, rate or extent of protein binding.
    GO:1900122    positive regulation of receptor binding    Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor.
    GO:0048260    positive regulation of receptor-mediated endocytosis    Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
    GO:1904437    positive regulation of transferrin receptor binding    Any process that activates or increases the frequency, rate or extent of transferrin receptor binding.
    GO:0042026    protein refolding    The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones.
    GO:0003254    regulation of membrane depolarization    Any process that modulates the rate, frequency or extent of membrane depolarization. Membrane depolarization is the process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive.
    GO:0002237    response to molecule of bacterial origin    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
    GO:0001895    retina homeostasis    A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
cellular component
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:1990712    HFE-transferrin receptor complex    A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription.
    GO:0042612    MHC class I protein complex    A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005925    focal adhesion    Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    D12  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NO3  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    PII  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    TWT  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    His B:31 - Pro B:32   [ RasMol ]  
    Tyr A:212 - Pro A:213   [ RasMol ]  
    Tyr A:92 - Pro A:93   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1gzq
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  B2MG_GORGO | P61771
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  B2MG_HUMAN | P61769
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  B2MG_PANTR | P61770
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  CD1B_HUMAN | P29016
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  105200
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  B2MG_GORGO | P61771
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  B2MG_HUMAN | P61769
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  B2MG_PANTR | P61770
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  CD1B_HUMAN | P29016
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        B2MG_GORGO | P617711e27 1e28 1eey 1eez 1gzp 1hsb 1i7r 1i7t 1i7u 1ktl 1m6o 1of2 1oga 1ogt 1onq 1qew 1qlf 1s8d 1t1w 1t1x 1t1y 1t1z 1t20 1t21 1t22 1uqs 1ur7 1uxs 1uxw 4gkn
        B2MG_HUMAN | P617691a1m 1a1n 1a1o 1a6z 1a9b 1a9e 1agb 1agc 1agd 1age 1agf 1akj 1ao7 1b0g 1b0r 1bd2 1c16 1ce6 1cg9 1de4 1duy 1duz 1e27 1e28 1eey 1eez 1efx 1exu 1gzp 1hhg 1hhh 1hhi 1hhj 1hhk 1hla 1hsa 1hsb 1i1f 1i1y 1i4f 1i7r 1i7t 1i7u 1im3 1im9 1jf1 1jgd 1jge 1jht 1jnj 1k5n 1kpr 1ktl 1lds 1lp9 1m05 1m6o 1mhe 1mi5 1n2r 1of2 1oga 1ogt 1onq 1p7q 1py4 1q94 1qew 1qlf 1qqd 1qr1 1qrn 1qse 1qsf 1qvo 1r3h 1s8d 1s9w 1s9x 1s9y 1sys 1syv 1t1w 1t1x 1t1y 1t1z 1t20 1t21 1t22 1tmc 1tvb 1tvh 1uqs 1ur7 1uxs 1uxw 1vgk 1w0v 1w0w 1w72 1x7q 1xh3 1xr8 1xr9 1xz0 1ydp 1ypz 1zhk 1zhl 1zs8 1zsd 1zt4 1zvs 2a83 2ak4 2av1 2av7 2axf 2axg 2bck 2bnq 2bnr 2bsr 2bss 2bst 2bvo 2bvp 2bvq 2c7u 2cii 2cik 2clr 2d31 2d4d 2d4f 2dyp 2e8d 2esv 2f53 2f54 2f74 2f8o 2fyy 2fz3 2git 2gj6 2gt9 2gtw 2gtz 2guo 2h26 2h6p 2hjk 2hjl 2hla 2hn7 2j8u 2jcc 2nw3 2nx5 2p5e 2p5w 2po6 2pye 2rfx 2uwe 2v2w 2v2x 2vb5 2vlj 2vlk 2vll 2vlr 2x4n 2x4o 2x4p 2x4q 2x4r 2x4s 2x4t 2x4u 2x70 2x89 2xks 2xku 2xpg 2ypk 2ypl 2yxf 2z9t 3am8 3b3i 3b6s 3bgm 3bh8 3bh9 3bhb 3bo8 3bp4 3bp7 3bvn 3bw9 3bwa 3bxn 3bze 3bzf 3c9n 3cdg 3cii 3ciq 3czf 3d18 3d25 3d2u 3d39 3d3v 3dbx 3dhj 3dhm 3dtx 3dx6 3dx7 3dx8 3dxa 3ekc 3ffc 3fqn 3fqr 3fqt 3fqu 3fqw 3fqx 3ft2 3ft3 3ft4 3giv 3gjf 3gsn 3gso 3gsq 3gsr 3gsu 3gsv 3gsw 3gsx 3h7b 3h9h 3h9s 3hae 3hcv 3hg1 3hla 3hpj 3huj 3i6g 3i6k 3i6l 3ib4 3ixa 3jts 3kla 3kpl 3kpm 3kpn 3kpo 3kpp 3kpq 3kpr 3kps 3kww 3kxf 3kyn 3kyo 3l3d 3l3g 3l3i 3l3j 3l3k 3lkn 3lko 3lkp 3lkq 3lkr 3lks 3ln4 3ln5 3low 3loz 3lv3 3m17 3m1b 3mgo 3mgt 3mr9 3mrb 3mrc 3mrd 3mre 3mrf 3mrg 3mrh 3mri 3mrj 3mrk 3mrl 3mrm 3mrn 3mro 3mrp 3mrq 3mrr 3mv7 3mv8 3mv9 3myj 3myz 3mzt 3na4 3nfn 3o3a 3o3b 3o3d 3o3e 3o4l 3ov6 3ox8 3oxr 3oxs 3pwj 3pwl 3pwn 3pwp 3qda 3qdg 3qdj 3qdm 3qeq 3qfd 3qfj 3qzw 3rew 3rl1 3rl2 3rwj 3s6c 3sdx 3sjv 3skm 3sko 3spv 3t8x 3tid 3tie 3tlr 3tm6 3to2 3tzv 3u0p 3upr 3utq 3uts 3utt 3v5d 3v5h 3v5k 3vcl 3vfm 3vfn 3vfo 3vfp 3vfr 3vfs 3vft 3vfu 3vfv 3vfw 3vh8 3vri 3vrj 3vwj 3vwk 3vxm 3vxn 3vxo 3vxp 3vxr 3vxs 3vxu 3w0w 3w39 3wl9 3wlb 3wuw 3x11 3x12 3x13 3x14 4e0k 4e0l 4e5x 4en3 4eup 4f7m 4f7p 4f7t 4ftv 4fxl 4g8g 4g8i 4g9d 4g9f 4gkn 4gks 4gup 4hkj 4hwz 4hx1 4i48 4i4w 4jfd 4jfe 4jff 4jfo 4jfp 4jfq 4jqv 4jqx 4jrx 4jry 4k71 4k7f 4kdt 4l29 4l3c 4l3e 4l4t 4l4v 4lcw 4lcy 4lhu 4lnr 4m8v 4mj5 4mj6 4mji 4mnq 4n0f 4n0u 4n8v 4nnx 4nny 4no0 4no2 4no3 4no5 4nqc 4nqd 4nqe 4nqv 4nqx 4nt6 4o2c 4o2e 4o2f 4ono 4pj5 4pj7 4pj8 4pj9 4pja 4pjb 4pjc 4pjd 4pje 4pjf 4pjg 4pjh 4pji 4pjx 4pr5 4pra 4prb 4prd 4pre 4prh 4pri 4prn 4prp 4qok 4qrp 4qrq 4qrr 4qrs 4qrt 4qru 4r9h 4ra3 4rah 4rmq 4rmr 4rms 4rmt 4rmu 4rmv 4rmw 4u1h 4u1i 4u1j 4u1k 4u1l 4u1m 4u1n 4u1s 4u6x 4u6y 4uq2 4uq3 4wc8 4wdi 4wj5 4wo4 4wu5 4wu7 4wuu 4ww2 4wwk 4x0s 4x6c 4x6d 4x6e 4x6f 4xxc 4z76 4z77 4z78 4zez 5b38 5b39 5bjt 5brz 5bs0 5bxf 5c07 5c08 5c09 5c0a 5c0b 5c0c 5c0d 5c0e 5c0f 5c0g 5c0i 5c0j 5c9j 5cfh 5cka 5ckg 5cs7 5csb 5csg 5d2l 5d2n 5d5m 5d7i 5d7j 5d7l 5d9s 5ddh 5def 5deg 5e00 5e6i 5e9d 5enw 5eo0 5eo1 5eot 5eu3 5eu4 5eu5 5eu6 5euo 5f7d 5f9j 5fa3 5fa4 5fdw 5gr7 5gsb 5gsr 5gsv 5gsx 5hga 5hgb 5hgd 5hgh 5hhm 5hhn 5hho 5hhp 5hhq 5hyj 5ib1 5ib2 5ib3 5ib4 5ib5 5ieh 5iek 5im7 5inc 5ind 5iro 5isz 5iue 5j1a 5jhd 5jzi 5knm 5l2j 5l2k 5men 5meo 5mep 5meq 5mer 5n1y 5swq 5t6w 5t6x 5t6y 5t6z 5t70 5u16 5u17 5u1r 5u2v 5u6q 5u72 5v5l 5v5m 5vgd 5vge 5xos 5xot 5xov
        B2MG_PANTR | P617701e27 1e28 1eey 1eez 1gzp 1hsb 1i7r 1i7t 1i7u 1ktl 1m6o 1of2 1oga 1ogt 1onq 1qew 1qlf 1s8d 1t1w 1t1x 1t1y 1t1z 1t20 1t21 1t22 1uqs 1ur7 1uxs 1uxw 2av1
        CD1B_HUMAN | P290161gzp 1uqs 2h26 3ov6 3t8x 4ono 5c9j 5l2j 5l2k

(-) Related Entries Specified in the PDB File

1a1m MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM GAG PROTEIN OF HIV2
1a1n MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE NEF PROTEIN (75- 82) OF HIV1
1a1o MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM
1a6z HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
1a9b DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1a9e DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1agb ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION)
1agc ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION)
1agd ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE)
1age ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION)
1agf ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION)
1akj COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL CORECEPTOR CD8
1ce6 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE
1de4 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR
1e27 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI)
1e28 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI)
1efx STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
1exu CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR
1gzp CD1B IN COMPLEX WITH GM2 GANGLIOSIDE
1hhg
1hhh
1hhi
1hhj HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)
1hhk
1hla HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN LEUCOCYTE ANTIGEN)
1hsa HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705
1hsb CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN)
1i4f CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX
1i7r CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058
1i7t CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V
1i7u CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V
1im3 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
1im9 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
1jf1 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A
1jht CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A.
1jnj NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN
1qlf MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
1qqd CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR
1tmc TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK)
2clr HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED WITH A DECAMERIC PEPTIDE FROM CALRETICULIN
2hla HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, HUMAN LEUCOCYTE ANTIGEN)
3hla HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN)